Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01240213 · ClinicalTrials.gov registry record · NA

Vitamin D, Diet and Activity Study

A NA study, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
218
Enrollment target

NCT01240213 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 218 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01240213, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
218 participants
Enrollment target

Study Summary

Experimental and human data suggests that vitamin D could protect against breast cancer. Overweight/obese individuals are at increased risk of low vitamin D levels. Vitamin D may reduce production of fat tissue, thereby reducing weight gain, which would result in lower levels of adipose-derived hormones and other breast cancer risk factors.The purpose of this study is to test the effect of vitamin D supplementation on the response to a weight loss (diet + exercise) intervention and select breast cancer risk factors in overweight and obese postmenopausal women with low blood vitamin D levels.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Vitamin D

Trial Details

FieldValue
Enrollment Target 218 participants
Start Date 2010-10
Est. Completion 2012-09
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT01240213

The ClinicalTrials.gov registry entry for NCT01240213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 218 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01240213 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01240213 about?

NCT01240213 is a clinical study titled "Vitamin D, Diet and Activity Study". Experimental and human data suggests that vitamin D could protect against breast cancer. Overweight/obese individuals are at increased risk of low vitamin D levels. Vitamin D may reduce production of fat tissue, thereby reducing weight gain, which would result in lower levels of adipose-derived horm...

What is the current status of trial NCT01240213?

This trial is currently completed. It is a NA study. The enrollment target is 218 participants. The study started on 2010-10. Estimated completion is 2012-09.

What interventions are being tested in trial NCT01240213?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Vitamin D (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01240213?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.